Fig 1.
(a) Schematic Flowchart of the iTRAQ method.
(b) Relative abundance of S100A2.
Fig 2.
Differentially expressed proteins categorized by (a) biological process, (b) PANTHER protein class and (c) molecular function.
Fig 3.
Relative expression levels of 12 mRNAs, normalized to GAPDH.
Fig 4.
A representative Western Blot for expression of S100A2, FGB, KRT17, FN1 and POSTN in the laryngeal carcinoma tissues.
Fig 5.
Representative immunohistochemistry images of S100A2, FN1, KRT17 and POSTN in tumor (left) and non-tumor (right) tissue samples.
Fig 6.
Representative images of functional studies of HEp-2 cells.
(a) Relative expression of S100A2 in siRNA silenced cells. (b) Cell invasion capacity of S100A2-silenced HEp-2 cells. (c) Cell migration capability in S100A2-silenced HEp-2 cells.